How many insider declarations does 인트론바이오 have?

인트론바이오 has filed 17 insider declarations with DART (FSS).

Who is the top reporting insider at 인트론바이오?

The top reporting insider at 인트론바이오 is 윤성준, based on the count of public filings.

What is the net insider buy vs sell volume on 인트론바이오?

Across the available history, declared buys total 0 and disposals 0.

InsiderTradesSIGMA

InsidersTradesSigma

인트론바이오 (048530.KQ) | Insider Transactions · Healthcare

← Companies ★ Sign in to follow

인

인트론바이오: management transactions · South Korea · DART (FSS)

DART:company-8a37c4KR·DART (FSS)Mcap 95.3Bn€Healthcare

AMF ↗

Browse the full directors' dealings record of 인트론바이오, a listed equity based in South Korea. Shares are quoted on KR KR, under the oversight of DART (FSS). Operating in the Healthcare sector, 인트론바이오 has published 17 reports. Market capitalisation: €95.3bn. The latest transaction was disclosed on 19 March 2026 (Sale). Among the most active insiders: 윤성준. All data is free.

Insider Decl.

Thresholds

5 ops.

Buy Volume

1 ops.

Sell Volume

Financial data

FY ended December 2025 · cache

3085.00 €

Analyst consensus

Income statement

Revenue5.74 Bn€

Gross profit3.10 Bn€54% margin

Net income−8.96 Bn€-156.1% margin

Valuation

Beta0.15

Balance sheet & cash

Market cap95.30 Bn€

Total debt3.35 Bn€

Free Cash Flow−7.68 Bn€

Debt / Equity5%

Profitability & ownership

ROE-11.7%

ROA-6.1%

% insiders18.6%

% institutions0.5%

Last declaration on 19 March 2026

Declarations17 total

Executives●Sale3DART

전

전수연전수연

ShareKRX

DART:20260319000656·19 Mar 2026